Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Solasto Corp. ( (JP:6197) ) just unveiled an announcement.
MP-2605 Co., Ltd., which shares leadership with Solasto Corporation, has filed an amendment to its tender offer registration statement with the Kanto Local Finance Bureau regarding its ongoing tender offer for Solasto’s common shares. In line with this filing, Solasto announced that the previously issued public notice of the commencement of the tender offer, dated March 25, 2026, will be amended accordingly, signaling an adjustment to the terms or conditions of the takeover process that stakeholders will need to monitor.
The disclosure, made pursuant to Japan’s Financial Instruments and Exchange Act at the request of MP-2605, formalizes the procedural update to the tender offer documentation for regulatory compliance. While the company has not detailed the specific changes, the move underscores that the proposed acquisition of Solasto’s shares remains active and subject to evolving terms that could influence shareholder decision-making and the company’s future governance structure.
The most recent analyst rating on (JP:6197) stock is a Hold with a Yen1216.00 price target. To see the full list of analyst forecasts on Solasto Corp. stock, see the JP:6197 Stock Forecast page.
More about Solasto Corp.
Solasto Corporation is a Japan-based company listed on the Tokyo Stock Exchange Prime Market under securities code 6197. The group operates in the healthcare and related services sector, providing support services to medical institutions and other clients across Japan. Its operations are subject to Japan’s Financial Instruments and Exchange Act and related cabinet orders, reflecting its status as a publicly traded entity.
Average Trading Volume: 1,778,354
Technical Sentiment Signal: Buy
Current Market Cap: Yen105.7B
Learn more about 6197 stock on TipRanks’ Stock Analysis page.

